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Abstract 
Purpose: To evaluate the protective mechanisms afforded by pterostilbene against intestinal 
ischemia/reperfusion ( II/R ) injury in Wistar rats.  
Methods: Male Wistar rats were divided into 4 groups as follows: Control group; intestinal 
ischemia/reperfusion (II/R) group; pterostilbene only group (20 mg/kg) of body weight and pterostilbene 
followed by intestinal ischemia/reperfusion (II/R) treated group. The study evaluated oxidative stress 
markers, including reactive oxygen species (ROS) and lipid peroxide levels, protein carbonyl content, 
antioxidant status (superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase, 
glutathione content) and membrane-bound ATPase activity. The levels of pro-inflammatory mediators, 
including nuclear factor- kappa B (NF-ߢB), cyclooxygenase-2 (COX-2) and inflammatory cytokines 
(TNF-α and IL-1β), were also evaluated.  
Results: The results showed that pterostilbene (20 mg/kg) followed by intestinal ischemia/reperfusion 
(II/R) significantly lowered the level of lipid peroxidation (41.33 %), protein carbonyl content (PCC, 44.18 
%) and ROS (29.14 %) (p < 0.001) but significantly restored membrane-bound ATPase activities 
(Ca2+ATPase, 30.76 %; Na+/K+ATPase, 21.42 %; Mg2+ATPase, 30.06 %) (p < 0.003), compared with 
rats induced with II/R. Furthermore, pterostilbene significantly down-regulated NF-ߢB and COX-2 
expressions (30 %, p < 0.05) compared to rats with II/R injury. 
Conclusion: The study reveals that pterostilbene offers significant protective activity in rats owing to its 
antioxidant and anti-inflammatory properties. 
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Intestinal ischemic reperfusion (II/R) injury occurs 
during aneurysm surgery, cardiopulmonary 
bypass, strangulated hernias and intestinal 
transplantation [1]. In II/R injury, interruption of 
the blood supply causes ischemic injury which 
results in tissue damage.  Restoration of blood 
flow to ischemic site results in reperfusion injury, 
which further exacerbates oxidative stress than 
that of initial ischemic injury. Reports have 
demonstrated that alteration in the absorptive 
function of the intestine occurs following II/R 
injury [2]. Pathogenesis of intestinal ischemia 
reperfusion injury(IRI) are known to be mediated 
through reactive oxygen and nitrogen species, 
nitric oxide, inflammatory cytokines, complement 
activation and polymorph nuclear neutrophil [3]. 
However, an imbalance in redox homeostasis at 
the cellular level is the first major deleterious 
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effect which causes propagation of ischemia 
reperfusion injury IRI. Thus an effective strategy 
to completely protect from IRI injury could be 




hydroxystilbene) is a naturally derived compound 
similar in structure to resveratrol with increasing 
bioavailability. The methoxy group in 
pterostilbene is responsible for oral absorption 
and lipophillic properties. Therapeutic 
performance might be due to increased 
bioavailability of pterostilbene (80 %) which is 
much higher when compared to that of 
resveratrol (20 %) [5]. Pterostilbene is an 
excellent antioxidant [6] with plethora of 
pharmacological effects including anti-
proliferative, anti-cancer and anti-inflammatory 
activities in vitro and in vivo [7]. The major 
protective role of pterostilbene is mediated 
through enhanced antioxidant defense 
mechanisms against oxidative stress conditions 
[8]. The present study was aimed at determining 
the protective effect of pterostilbene on intestinal 
ischemia reperfusion injury-induced oxidative 






Male Wistar rats weighing 150–250 g were used 
for the present study. The rats were housed 
under optimum conditions of 21 ± 1 ºC and 
relative humidity of 50-70 % with alternating dark 
and light cycle.  The animals were fed with 
standard rat pellets and water (ad libitum). After 
the period of acclimatization, they were randomly 
divided into 4 groups with six animals per group. 
The rats were maintained in accordance with the 
Chinese legislation guidelines and the 
international guidelines on the protection, care 
and handling of laboratory animals and all the 
protocols were approved by the Ethical 
Committee of Third Affiliated Hospital of Harbin 
Medical University, China (approval Ref. no: 
CLG/TAHHMU/2014/00752). 
 
Experimental groups  
 
Group I (Control):  The control rats were 
operated with surgical steps; however, the 
animals were not subjected to intestinal ischemia 
reperfusion (I/R). Group II (Intestinal I/R): The 
rats were subjected to intestinal ischemia for 30 
min followed by reperfusion for 60 min. Group III 
(Pterostilbene): Pterostilbene (20 mg/kg body 
weight) was administered for 5 consecutive days 
through gavage. Group IV (Pterostilbene + 
Intestinal I/R): Pterostilbene (20 mg/kg body 
weight) was administered for 5 consecutive days 
through gavage. Later, the rats were subjected to 
intestinal ischemia for 30 min, followed by 
reperfusion for 60 min.  
 
After the treatment schedule, the rats were 
allowed to fast for 12 h. Following which the 
animals were anaesthetized and dissected intra-
peritoneally (1500 mg/kg). During the whole 
process of dissection, the body temperature of 
the animals was maintained at 37.5 ºC, with the 
help of heating lamp. The intestinal I/R were 
performed according to methods of Guneli et al 
[9]. Briefly, the abdominal region of the rats was 
sterilized with povidine iodine solution and then 
shaved. The intestinal region was subjected to 
midline laparotomy and intestinal I/R injury were 
created in superior mesenteric artery (SMA) 
which was occluded with a traumatic micro 
vascular clamp for 30 min. The abdominal region 
was closed and on completion of ischemia, the 
clamp was removed and reperfusion was 
induced for 60 min. After the complete I/R injury 
the jejunal segment was removed and the 
animals were sacrificed by exsanguination. The 
blood collected was centrifuged and serum was 
stored at -70 ºC. The tissues were rinsed with ice 
cold saline and blood was completely removed. 
The tissues were homogenized using Tris-HCl 
buffer (50 mM, pH 7.4) at 4 ºC and centrifuged at 
3000 rpm for 30 min. The supernatant was 
removed and aliquoted in small volumes and 
stored at -70 ºC for biochemical analysis. 
 
Estimation of oxidative stress 
 
Lipid peroxidation: The lipid peroxide levels were 
determined as described previously [10]. The 
lipid peroxidation is was observed by reaction 
between MDA (Malondialdehyde) , thiobarbituric 
acid & lipid peroxides resulting pink color formed 
is measured spectrophometrically at 532 nm. 
Results were expressed as nanomol TBA 
(Thiobarbituric acid) reactants formed/g wet 
tissue.  
 
Protein carbonyl content (PCC) 
 
The reaction between carbonyl group and 2, 4-
dinitrophenylhydrazine results in the formation of 
protein carbonyl content. These were measured 
spectrophotometrically at 370 nm.  The results 
were expressed as nanomoles of carbonyl/ mg of 
protein [11]. 
 
Reactive oxygen species generation 
 
The tissue homogenate was incubated with 2', 7' 
- dichlorofluorescein diacetate DCF-DA at 37 ºC 
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for 15 min. After 15 min, it was centrifuged at 
10,000 rpm, 30 min. The supernatant was 
discarded and the pellet was re-suspended in 
PBS solution (phosphate buffered saline) and 
incubated for 60 min at 37 ºC. The levels of ROS 
were measured spectrophotometrically at an 
excitation wavelength (485 nm) and emission 
wavelength (528 nm). The results were 
calculated as percentage of ROS generation 
when compared with control group [12].  
 





The tissue homogenate was treated with 5 % 
meta-phosphoric acid followed by which the 
supernatant was collected for determining total 
glutathione (Glutathione assay kit; Trevigen Inc., 
Gaithersburg, MD). The concentration of GSH 
was determined from the standard GSH 
concentration curve. The results of GSH levels 
were expressed as nmol/mg of protein. 
 
Total (Cu–Zn and Mn) SOD activity 
 
Ethanolic phase of the tissue homogenate was 
extracted using ethanol-chloroform mixture (5:3, 
v/v) and used for determining SOD activity. The 
assay was carried out according to the principle 
of nitro blue tetrazolium (NBT) reduction assay 
[13]. 1 U of SOD activity = amount required for 
50 % inhibition of NBT reduction. The SOD 
activity is expressed as U/ mg of protein. 
 
Catalase (CAT) activity 
 
The activity was determined according to the 
method described by Aebi [14]. The reaction 
mixture contained sample in 30 mM H2O2 in a 50 
mM phosphate buffer pH 7.0. The activity was 
estimated by decreased in absorbance of H2O2 




The GPx was performed as described Paglia et 
al [15]. Oxidized glutathione (GSSG) is reduced 
by glutathione reductase and NADPH. The 
oxidation of NADPH to NADP+ is measured by 
decrease in absorbance at 340nm. GPx activity 
is expressed as U /mg of protein.  
 
Glutathione-S-transferase (GST) activity 
 
The GST activity was determined as described 
Habig et al [16]. The assay involves reaction 
between 1-chloro-2, 4-dinitro benzene (CDNB) 
and reduced glutathione which ultimately results 
in formation of dinitro phenyl thioether. The 
formed product is measured spectrophoto-
metrically at 340 nm and the enzyme activity was 
calculated. 1 U = Amount of enzyme producing 1 
mmol of CDNB-GSH conjugate/min. 
 
ATPase activities (Na+/K+, Ca2+, and Mg2+ 
ATPases) 
 
The ATPases activity was determined by 
measuring the levels of inorganic phosphorous 
(Pi) liberated. The phosphate reacts with 
ammonium molybdate to form phosphor-
molybdate. The reaction between ANSA and 
phosphomolybdate results in formation of blue 
color complex, measured at 620 nm. Tissue 
Na+/K+ ATPase were determined according to 
the method of Bonting [17]. Tissue Mg2+ ATPase 
was determined according to the method of 
Ohnishi [18] and Ca2+ ATPase was determined 
according to the method of Hjerten and Pan [19]. 
The results were expressed as nmoles Pi-
released/min/mg of protein. 
 
Evaluation of serum TNF- α and IL-1β levels 
 
The serum interleukins TNF-α and IL-1β levels 
were determined using an ELISA kit (R&D 
system Inc, MN, USA). The levels of interleukins 
were expressed as pg/ml. 
 
Western blot analysis 
 
For NF-ߢB expression study, nuclear extracts 
were isolated. The tissue samples were washed 
with ice-cold PBS thrice. The samples were 
homogenized in lysis buffer containing 10 mM 
HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 
mM EGTA, 1 mM DTT, 0.75 mM spermidine, 
0.15 mM spermine, 20 mM PNPP, 20 mM b-
glycerophosphate, 1 mM Na3VO4, 1 mM PMSF 
and protease inhibitor cocktail. The homogenate 
was incubated in ice for 20 min. Followed by 
which NP- 40 (10 %) was added and incubated 
for 10 min. After incubation time, centrifugation 
was carried out at 15,000 rpm for 20 min. The 
supernatant was discarded and the pellet were 
resuspended in nuclear extraction buffer 
containing 20 mM HEPES pH 7.9, 400 mM NaCl, 
1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.75 mM 
spermidine, 0.15 mM spermine, 20 mM PNPP, 
20 mM b-glycerophosphate, 1 mM Na3VO4, 1 
mM PMSF and 1:100 protease inhibitor. The 
samples were subjected to 3 cycle of freezing 
and thawing. The extract was centrifuged at 
10,000 rpm for 20 min at 4 ºC. The supernatant 
containing nuclear extracts were aliquoted and 
stored at -80 ºC until further analysis. For COX-2 
expression, tissues were homogenized in ice-
cold lysis buffer (50 mM  Tris–HCl,  pH  7.4,  150  
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mM  NaCl,  5  mM  EDTA,  50  mM  NaF,  1 % 
Triton  X-100,  1  mM sodium  ortho vanadate,  1  
mM  phenyl methanesulfonyl  fluoride,  1  mg/mL  
aprotinin,  4  µg/ml pepstatin A, and 5 µg/mL 
leupeptin). The homogenate was then 
centrifuged for 20 min at 13,000 rpm at 4 °C. The 
supernatant was analyzed for protein 
concentration according to the method described 
by Lowry [20]. 
 
Protein from different samples at a concentration 
of 50 μg was separated using SDS-PAGE and 
transferred to PVDF membranes. The 
membranes were blocked with 5 % nonfat milk in 
Tris-buffered saline (TBS) and subsequently 
incubated with NF-ߢB, COX-2 (1:500) or β-actin, 
GAPDH primary antibody, followed by 
horseradish peroxidase-conjugated goat, anti-
rabbit or -mouse IgG secondary antibody and 
bands were visualized with an enhanced 
chemiluminescence (ECL) system according to 
the manufacturer’s instructions. Densitometric 
analyses of the Western blot bands were 
performed using optical density scanning and 




Data were analyzed with SPSS 11.0 (SPSS Inc. 
Software, Chicago, Illinois, USA) statistical 
software using one-way analysis of variance 
(ANOVA) and with Tukey-Kramer test so as to 
determine comparison between groups, and 
differences between groups, respectively. All 
values were expressed as mean ± SD and p < 
0.05 was considered statistically significant. 
RESULTS 
 
Pterostilbene ameliorates oxidative stress  
 
The study shows a significant rise (p < 0.001) in 
the lipid peroxide, PCC and ROS generation (p < 
0.001) in rats with II/R. However, rats treated 
with Pterostilbene (20 mg/kg body weight) 
followed by intestinal I/R (group 4) showed a 
significant decline the levels of lipid peroxidation 
(41.33 %; p < 0.001), PCC (44.18 %; p < 0.001) 
and ROS (29.14 %; p < 0.001) generation when 
the results were compared with rats induced with 
II/R (group 2).  Rats treated with pterostilbene 
alone showed non- significant difference in lipid 
peroxide, PCC and ROS when compared to 
control rats (Fig. 1). 
 
Pterostilbene enhances antioxidant status 
during Intestinal I/R injury 
 
Table 1 shows a significant decrease in 
antioxidant enzyme activities of GSH, SOD, CAT, 
GPx and GST in rats induced with II/R injury 
when compared to sham operated rats. 
Treatment with pterostilbene followed by II/R 
injury significantly enhanced the antioxidant 
status when compared to rats subjected to II/R 
injury alone. There was a non-significant change 
in the levels of antioxidant status in palone 






Fig 1A: Pterostilbene inhibits ROS generation. Results shown indicate ROS generated (%). ***Indicates 
Significant rise (p < 0.001, compared with control group; ###significant reduction (p < 0.001, compared with 
intestinal I/R injury rats; NS = no significant difference 
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Fig 1B: Pterostilbene inhibits lipid peroxidation. The results are expressed as nano moles of TBA reactants 
formed/mg of protein; (p < 0.05, compared with control group; ###significant reduction (p < 0.001, compared with 
intestinal I/R injury rats; NS = no significant difference 
 
 
Fig 1C: Pterostilbene reduces protein carbonylation. The results are expressed as nanomoles of protein carbonyl 
formed/mg; ###significant reduction (p < 0.001) compared with intestinal I/R injury rats; NS = not significant. 
Results are given as the mean ± SEM (n = 6) 
 
Table 1:  Effect of Pterostilbene on enzymic and non-enzymic antioxidant status in intestinal Ischemic reperfusion 
injury rats 
 
Parameter Group I Group II £ Group III ££ Group IV £££ 
GSH 65 ± 2.19 21 ± 1.78*** 61 ± 1.90 NS 55 ± 1.10### 
SOD 167 ± 3.21 34 ±1.0*** 172 ± 2.98 NS 145± 2.75### 
CAT 4.8±0.89 1.76±0.12*** 4.6±0.71 NS 3.48 ± 0.9### 
GPX 1.7±0.001 0.2  ± 0.001*** 1.5  ± 0.001 NS 1.18  ± 0.001### 
GST 51±2.45 13±1.12*** 50±1.89 NS 42±1.01### 
Group I (sham); Group II (Intestinal I/R injury rats); Group III (Pterostilbene); Group IV (Pterostilbene + Intestinal 
I/R injury rats): Results are given as the mean ± SEM for 6 rats in each group. For GSH levels the results are 
expressed as nanomoles of GSH/g of tissue. For antioxidant enzyme activities the results are expressed as U/mg 
of protein; £ significant differences when compared with sham group (Group 1) (***p < 0.001); ££ no significant 
differences when compared with sham group (Group 1) NS p < 0.004); £££ significant differences when compared 
with Intestinal I/R group (Group II) (###p < 0.001) 
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Pterostilbene restores membrane bound-
ATPase activities 
 
Rats with intestinal I/R injury showed a significant 
decline (p < 0.03) in the activities of Na+/K+, Ca2+, 
and Mg2+ ATPases when compared to sham 
operated rats. However, the activities were 
normal with non-significant change in rats treated 
with pterostilbene treated rats alone. 
Pterostilbene treatment followed by II/R injury 
significantly reversed enzyme activities with 
increase (Na+/K+ ATPase-21 %, Ca2+ ATPase-
30.76 %, and Mg2+ ATPases-30.06 % p < 0.03) 
when compared to rats with II/R injury alone (Fig 
2). 
Pterostilbene down regulates NF-ߢB, COX-2 
expression 
 
The effect of pterostilbene on NF-ߢB, COX-2 
expression during intestinal I/R injury was 
determined by western blot analysis (Fig. 3). The 
results show a significant increase (p < 0.001) in 
the expression levels of NF-ߢB, COX-2 during 
rats induced with II/R injury. Treatment with 
Pterostilbene significantly down regulated the 
NF-ߢB (58.33 %; p < 0.05), COX-2 (70 %; p < 




Figure 2: Pterostilbene maintains ATPase enzyme activities in ischemic injury in Wistar rats. Results are 
expressed as phosphate ion (Pi) liberated/min/mg of protein; *** indicates significant change (p < 0.03), Vs sham 
group. ### Significantly maintains all ATPase (p < 0.03), when compared to intestinal I/R injury group. NS = not 
significant when compared to control group; Results are given as mean ± SEM (n = 6) 
 
          
Figure 3: Pterostilbene exhibits anti-inflammation through down regulation of NF-ߢB and COX 2 expressions in 
Intestinal Ischemic injury in wistar rats A. Western blot analysis of NF-ߢB  expression; B. Western blot analysis of 
COX- 2 expression C. Densitometric analysis of NF- kb and COX- 2 expressions. Statistical analyses were 
carried out by Students t-test. The results are expressed as mean ± SEM. ***p < 0.001 compared with control 
rats; ###significant reduction was observed (p < 0.05), compared to rats with intestinal Ischemic injury. NS = not 
significant 
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Pterostilbene downregulated Interleukin 
levels (TNF-α and IL-1β) 
 
The results show that the levels of TNF-α and IL-
1β were significantly higher (p < 0.001) in rats 
induced with II/R. Treatment with tterostilbene 
followed by II/R injury (group 4) significantly 
down regulated the levels of TNF-α (31.81 %, p < 
0.05) IL-1β (52.94 %, p < 0.05) when compared 
to I/R (group 2) rats. There was a non-significant 
level of interleukin release in rats treated with 
pterostilbene alone when compared to sham 




Oxidative stress and its associated inflammation 
play a major role in intestinal I/R injury. Oxidative 
stress during I/R injury ensues as a result of 
imbalance between ROS generation and its 
scavenging mechanisms [21]. Thus, for an 
efficient protection against I/R injury, there must 
be an effective strategy for combating the initially 
generated reactive species. The present study 
shows for the first time, the protective role of 
pterostilbene in intestinal I/R injury in wistar rats. 
The data suggest that anti-oxidative and anti-
inflammatory properties of pterostilbene might be 
the related to its protective role.  
 
The present study shows that intestinal ischemia 
resulted in a significant increase in ROS 
generation and various oxidative stress 
mediators such as lipid peroxides and protein 
carbonyls. However, treatment with pterostilbene 
offered protection against intestinal I/R injury-
induced oxidative stress. The present study 
results are in line with Guven et al [22], clearly 
showing the imbalance in redox homeostasis in 
IIR injury. The antioxidant effects of pterostilbene 
have been largely studied which is in line with the 
present research findings. Significant increase in 
SOD activity during pterostilbene treatment has 
been shown in earlier studies on anti-proliferation 
against breast cancer cells [23].  
 
In addition to ROS and toxic mediators during 
exacerbation of oxidative stress, there is 
decrease in the inbound defense mechanisms. 
This ultimately results in inactivation various 
proteins and enzymes present in cellular 
membrane as a result of lipid peroxide effects, 
membrane bound ATPases included [24]. 
ATPase are involved in the normal ionic 
regulation which is highly responsible for normal 
tissue functioning. It is important to maintain 
proper ionic homeostasis for normal functioning 
of tissues. Estimation of enzyme activities of 
ATPases in the present study clearly shows that 
intestinal ischemia significantly inhibits these 
enzyme activities which were completely 
restored by treatment with antioxidant, 
pterostilbene. 
 
Fig 4: Pterostilbene exhibits anti-inflammation through downregulation of inflammatory cytokines (TNF- α and IL-
1β). A = effect of pterostilbene on TNF- α levels; ***p < 0.03 significantly different compared with control rats. ###p 
< 0.05, significant changes compared with Intestinal Ischemic injury were observed. B = effect of pterostilbene on 
IL-1β levels; ###p < 0.05 compared with rats with intestinal ischemic injury; results are given as mean ± SEM (n = 
6) 
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Thus the present study shows that the 
antioxidant effect of pterostilbene plays as a 
central mediator in the prevention of oxidative 
stress and protection against membrane bound 
ATPase activity.  The present study also shows 
that II/R injury resulted in significant up regulation 
of inflammatory proteins NF-ߢB, COX-2 and pro-
inflammatory cytokines TNF-alpha and IL-1β 




The present investigation highlights the 
protective role of pterostilbene in IIR injury in 
Wistar rats. The protection shown by 
pterostilbene is associated with the inhibition of 
oxidative stress and enhanced antioxidant status. 
Further, pterostilbene maintains ionic 
homeostasis by regulating ATPase enzyme 
activities. Pterostilbene, in addition, ameliorates 
IIR injury-induced pro-inflammatory genes and 
inflammatory cytokines. Thus, this study provides 
some insight into pterostilbene-mediated 
cytoprotection against IIR injury but there is a 
need for further elucidation of the exact 




1. Collard CD, Gelman S. Pathophysiology, clinical 
manifestations, and prevention of ischemia-
reperfusion injury. Anesthesiology 2001; 94(6): 1133-
1138. 
2. Prasad R, Alavi K, Schwartz MZ. GLP-2alpha accelerates 
recovery of mucosal absorptive function after 
intestinal ischemia/reperfusion. J Pediatr Surg 2001; 
36 (4): 570-572. 
3. Carden DL, Granger DN. Pathophysiology of ischaemia 
reperfusion injury. J Pathol 2000; 190(3): 255-266. 
4. Ustundag B, Kazez A, Demirbag M, Canatan H, 
Halifeoglu I, Ozercan H. Protective effect of melatonin 
on antioxidative system in experimental ischemia-
reperfusion of rat small intestine. Cell Physiol 
Biochem 2000 ; 10(4) : 229-236 
5. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, 
McCormick DL. Pharmacokinetics, oral bioavailability, 
and metabolic profile of resveratrol and its 
dimethylether analog, pterostilbene, in rats. Cancer 
Chemother Pharmacol 2011; 68(3): 593-
601. 
6. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. 
Resveratrol, pterostilbene, and piceatannol in 
Vaccinium berries. J Agric Food Chem 2004; 52(15): 
4709-4713. 
7. Chiou Y S, Tsai ML, Wang YJ, Cheng AC, Lai WM, 
Badmaev V,  Ho CT, Pan MH. Pterostilbene inhibits 
colorectal aberrant crypt foci (ACF) and colon 
carcinogenesis via suppression of multiple signal 
transduction pathways in azoxymethane-treated 
mice. J Agri Food Chem 2010; 58(15): 8833-8841. 
8. Zhang L, Zhou G, Song W, Tan X, Guo Y, Zhou B, Jing 
H, Zhao S, Chen L. Pterostilbene protects vascular 
endothelial cells against oxidized low-density 
lipoprotein-induced apoptosis in vitro and in vivo. 
Apoptosis 2012; 17(1): 25-36. 
9. Guneli E, Cavdar  Z, Islekel H, Sarioglu S, Erbayraktar S, 
Kiray M, Sokmen S, Yilmaz O, Gokmen N. 
Erythropoietin protects the intestine against ischemia/ 
reper fusion  injury  in  rats. Mol Med 2007; 13(9-10): 
509-517. 
10. Esterbauer H, Cheeseman KH: Determination of 
aldehydic lipid peroxidation products: malonaldehyde 
and 4-hydroxynonenal. Methods Enzymol 1990; 186: 
407-421. 
11. Levine RL, Garland D, Oliver CN, Amici A, Climent I, 
Lenz AG, Ahn B. W., Shaltiel S., Stadtman ER. 
Determination of carbonyl content in oxidatively 
modified proteins. Methods Enzymol 1990; 186: 464-
478. 
12. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, 
Shido O.Chronic administration of docosahexaenoic 
acid ameliorates the impairment of spatial cognition 
learning ability in amyloid beta-infused rats.J Nutr 
2005; 135(3): 549-555. 
13. Sun Y, Oberley LW, Li Y. A simple method for clinical 
assay of superoxide dismutase. Clin Chem 1988; 
34(3): 497-500. 
14. Aebi H. Catalase, in: Bergmeyer U (Ed). Methods of 
enzymatic analysis. New York, Academic Press 
1974; pp 673-677. 
15. Paglia DE, Valentine WN. Studies on the quantitative and 
qualitative characterisation of erythrocyte glutathione 
peroxidase. J Lab Clin Med 1967; 70(1): 158-169.  
16. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-
transferases. The first enzymatic step in mercapturic 
acid formation. J Biol Chem 1974; 249(22): 7109-
7130. 
17. Bonting SL. Sodium-potassium activated adenosine 
triphosphatase and cation transport, in: Bittar EE 
(Ed). Membranes and ion transport. London, Wiley-
Interscience, 1970; pp 257-263. 
18. Ohnishi T, Suzuki T, Suzuki Y, Ozawa KA Comparative 
study of plasma membrane Mg 2+ -ATPase activities 
in normal, regenerating and malignant cells. Biochim 
Biophy Acta 1982; 684(1): 67-74. 
19. Hjerten S, Pan H. Purification and characterization of two 
forms of a low-affinity Ca2+ -ATPase from 
erythrocyte membranes. Biochim Biophys Acta 1983; 
728(2): 281-288. 
20. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 
Protein measurement with the Folin phenol reagent. J 
Biol Chem 1951; 193(1): 265-275. 
21. Klune JR, Tsung A. Molecular biology of liver 
ischemia/reperfusion injury: Established mechanisms 
and recent advancements. Surg Clin North Am 2010; 
90(4): 665-677. 
Sun et al 
Trop J Pharm Res, August 2015; 14(8): 1391  
 
22. Guven A, Tunc T, Topal T, Kul M, Korkmaz A, Gundogdu 
G, Onguru O, Ozturk H. Alpha-lipoic acid and ebselen 
prevent ischemia/reperfusion injury in the rat 
intestine. Surg Today 2008; 38(11):1029-1035.  
23. Moon D, McCormack D, McDonald D, McFadden D. 
Pterostilbene induces mitochondrially derived 
apoptosis in breast cancer cells in vitro. J Surg Res 
2013; 180(2): 208-215.  
24. Carageorgiou H, Tzotzes V, Pantos C, Mourouzis C, 
Zarros A, Tsakiris S.  In vivo and in vitro effects of 
cadmium on adult rat brain total antioxidant status, 
acetylcholinesterase, (Na+,K+)-ATPase and Mg2+-
ATPase activities: protection by L-cysteine. Basic Clin 
Pharmacol Toxicol 2004; 94(3):112-118. 
 
